Key statistics dashboard for Retractable Technologies, Inc. (RVP). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Retractable Technologies, Inc. is a medical device company focused on the innovation, production, and sale of secure medical instruments, predominantly syringes, for the healthcare sector. Their reach extends across the United States, the broader North and South American continents, and other international territories.
Stock Data
| Price | $0.68 |
| Market Cap | $20M |
| Beta | 1.26 |
| Exchange | AMEX |
| Country | US |
Valuation Multiples
| P/E Ratio | -5.65 |
| Price / Book | 0.28 |
| P/S | 0.60 |
| P/FCF | -3.99 |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 1.10% |
| EBIT Margin | -9.68% |
| EBITDA Margin | 13.36% |
| Operating Margin | -66.90% |
| Net Margin | -9.94% |
Financial Health
| Current Ratio | 4.93 |
| Quick Ratio | 3.74 |
| Cash Ratio | 0.20 |
| Debt / Equity | 0.01 |
| Debt / Assets | 0.51% |
| Interest Coverage | -278.85 |
Per-Share Data
| Revenue per share | 1.13 |
| Book Value per share | 2.43 |
| Cash per share | 1.33 |
| FCF per share | -0.17 |
| Tangible Book Value per share | 2.43 |
| Dividend per share | 0.00 |
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of RVP: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks